Ovcharenko D V, Kaputin M Iu, Platonov S A
Angiol Sosud Khir. 2009;15(4):43-7.
The study was aimed at retrospectively assessing the outcomes of peripheral angioplasty (PAP) in patients presenting with lower limb critical ischaemia (LLCI) after previously endured operations off emoropopliteal bypass grafting (FPBG). The PAP procedure was carried out in a total of nine patients diagnosed with LLCI meeting the criteria of the Trans-Atlantic Inter-Society Consensus (TASC), in whom repeat bypass grafting was recognized impossible owing to the absence of either shunting-fit veins or arterial segments suitable for anastomosing. Of these, eight patients had a femoropoplietal bypass graft implanted previously, and the remaining patient had a femoral-anterior-tibial one. In four cases, the patency of the shunts was preserved but all the three tibial arteries were occluded. Five patients displayed total occlusion of the shunts. In 80% of cases, the PAP procedure was performed in C and D types of morphology of the arterial lesion according to the TASC criteria. The PAP procedure was technically successful in eight (89%) patients, making it possibly to re-establish blood supply to the foot along at least one tibial artery. No clinically significant complications following PAP in the treated patients were observed. The average duration of follow up amounted to 9 months. Technically successful PAP was accompanied by clinical success in all the cases. During the follow-up period, one patient died from myocardial infarction with no signs of LLCI. A relapse of LLCI was observed in one (12.5%) patient. The obtained findings suggest that in the treated patients with LLCI after FPBG and impossibility of performing repeat bypass grafting, PAP proved to be a safe and efficient method of revascularization.
本研究旨在回顾性评估在先前接受过股腘动脉旁路移植术(FPBG)后出现下肢严重缺血(LLCI)的患者中进行外周血管成形术(PAP)的效果。共有9例被诊断为LLCI且符合跨大西洋两岸社会共识(TASC)标准的患者接受了PAP手术,由于缺乏适合分流的静脉或适合吻合的动脉段,这些患者被认为无法进行再次旁路移植术。其中,8例患者先前植入了股腘动脉旁路移植,其余1例患者植入了股-胫前动脉旁路移植。4例患者分流通畅但所有3条胫动脉均闭塞。5例患者分流完全闭塞。根据TASC标准,80%的病例在动脉病变的C型和D型形态下进行了PAP手术。PAP手术在8例(89%)患者中技术成功,使得至少沿一条胫动脉重新建立足部血供成为可能。在接受治疗的患者中,未观察到PAP术后有临床显著并发症。平均随访时间为9个月。技术成功的PAP在所有病例中均伴随临床成功。在随访期间,1例患者死于心肌梗死,无LLCI迹象。1例(12.5%)患者出现LLCI复发。所得结果表明,对于接受FPBG后出现LLCI且无法进行再次旁路移植术的治疗患者,PAP被证明是一种安全有效的血运重建方法。